Shareholding for the Period Ended June 30, 2018
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here18-07-2018
18-07-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Advertisement of Audited Financial Results for the Quarter and Financial Year ended 31.03.2018 in the Newspapers23-05-2018
Bliss GVS Pharma - Earnings Presentation - Q4-FY18
Bliss GVS Pharma - Earnings Presentation - Q4-FY1817-05-2018
Board recommends Final Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2018, inter alia, has considered and approved the following:1. Declared Final dividend at the rate of 100% i.e. Rs. 1.00 per share.17-05-2018
Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from Saturday, 18th August, 2018 to Friday, 24th August, 2018 (both days inclusive)17-05-2018
Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31/03/2018
Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Annual Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31/03/201817-05-2018
Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on May 17, 2018, inter alia, to consider and transact the following businesses:1. To consider & approve inter alia, the Audited Standalone and Consolidated Financial Results of the Company for the year ended March 31, 2018;2. To recommend declaration of dividend for the financial year ended March 31, 2018, if any....04-05-2018